Stay updated on Arimoclomol in Myositis-Open Label Extension Clinical Trial
Sign up to get notified when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.

Latest updates to the Arimoclomol in Myositis-Open Label Extension Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision entry v3.5.4 was added to the page history, and the previous revision v3.5.3 was removed, indicating a site release update.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page footer now reflects a newer ClinicalTrials.gov interface revision (v3.5.3) in place of the prior one (v3.5.2). This indicates a site/software update rather than a change to the underlying study record.SummaryDifference0.1%

- Check42 days agoChange DetectedVersion updated to v3.5.2 and the previous v3.5.0 revision was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision history updated: a new version v3.5.0 was added and v3.4.3 was removed.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision history updated: a new site revision entry v3.4.3 has been added and v3.4.2 was removed. This change affects only UI/versioning metadata and does not alter trial data or content.SummaryDifference0.1%

- Check106 days agoChange DetectedAdded Revision: v3.4.2 to the record history. The funding status notice and Revision: v3.4.1 text were removed.SummaryDifference0.8%

Stay in the know with updates to Arimoclomol in Myositis-Open Label Extension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Arimoclomol in Myositis-Open Label Extension Clinical Trial page.